Intuitive Surgical, Inc. ($ISRG) reported its Q4 2024 financial results, revealing an adjusted earnings per share (EPS) of $2.21 and revenue of $2.41 billion, surpassing expectations by $174 million. The company also noted a net income of $686 million on a GAAP basis and $805 million on a non-GAAP basis. Year-over-year, revenue increased by 25.19%, and EPS rose by 38.12%. The installed base of da Vinci systems grew by 15%, with 493 new systems placed. However, the company faced some market disappointment due to conservative guidance for gross profit margins in 2025, leading to a pre-market decline of 2.2%. Analysts at Piper Sandler raised the price target for the stock to $670 from $538, citing strong Q4 results and potential for 14.6% revenue growth in FY25, while also highlighting the continued leadership of the da Vinci system with an 18% growth in procedures.